DPP-1 Inhibitors are used to treat inflammatory diseases caused by excessive neutrophil activity, including non-cystic fibrosis bronchiectasis. They work by binding to the DPP-1 enzyme and obstructing its activity, which reduces the activity of neutrophils.
How are these percentages calculated?These percentages are created by aggregating the total number of claims for the drugs in this class divided by the # of drugs with a specific indication. It is meant to be representative but may not accurately reflect the actual # of prescriptions written to treat specific condition.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up